BiCyCLE NMES—neuromuscular electrical stimulation in the perioperative treatment of sarcopenia and myosteatosis in advanced rectal cancer patients: design and methodology of a phase II randomised controlled trial
Authors:
- Edward T. PringEPEdward T. Pring
- Laura E. GouldLGLaura E. Gould
- George MalietzisGMGeorge Malietzis
- Philip LungPLPhilip Lung
- Mina BharalMBMina Bharal
- Tutu FadodunTFTutu Fadodun
- Paul BassettPBPaul Bassett
- Mani NaghibiMNMani Naghibi
- Claire TaylorCTClaire Taylor
- Ioanna DramiIDIoanna Drami
- Deeptika ChauhanDCDeeptika Chauhan
- Tamsyn StreetTSTamsyn Street
Open Access
- 15 September 2021
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-12
Abstract
Background: Colorectal cancer is associated with secondary sarcopenia (muscle loss) and myosteatosis (fatty infiltration of muscle) and patients who exhibit these host characteristics have poorer outcomes following surgery. Furthermore, patients, who undergo curative advanced rectal cancer surgery such as pelvic exenteration, are at risk of skeletal muscle loss due to immobility, malnutrition and a post-surgical catabolic state. Neuromuscular electrical stimulation (NMES) may be a feasible adjunctive treatment to help ameliorate these adverse side-effects. Hence, the purpose of this study is to investigate NMES as an adjunctive pre- and post-operative treatment for rectal cancer patients in the radical pelvic surgery setting and to provide early indicative evidence of efficacy in relation to key health outcomes.Method: In a phase II, double-blind, randomised controlled study, 58 patients will be recruited and randomised (1:1) to either a treatment (NMES plus standard care) or placebo (sham-NMES plus standard care) group. The intervention will begin 2 weeks pre-operatively and continue for 8 weeks after exenterative surgery. The primary outcome will be change in mean skeletal muscle attenuation, a surrogate marker of myosteatosis. Sarcopenia, quality of life, inflammatory status and cancer specific outcomes will also be assessed.Discussion: This phase II randomised controlled trial will provide important preliminary evidence of the potential for this adjunctive treatment. It will provide guidance on subsequent development of phase 3 studies on the clinical benefit of NMES for rectal cancer patients in the radical pelvic surgery setting.Trial registration: Protocol version 6.0; 05/06/20. ClinicalTrials.govNCT04065984. Registered on 22 August 2019; recruiting.Keywords
Funding Information
- St Mark's Hospital Foundation
This publication has 31 references indexed in Scilit:
- Impact of Resistance Training in Cancer SurvivorsMedicine & Science in Sports & Exercise, 2013
- Effect of early implementation of electrical muscle stimulation to prevent muscle atrophy and weakness in patients after anterior cruciate ligament reconstructionJournal of Electromyography and Kinesiology, 2011
- Thigh muscle volume predicted by anthropometric measurements and correlated with physical function in the older adultsThe Journal of nutrition, health and aging, 2010
- Skeletal muscle loss: cachexia, sarcopenia, and inactivityThe American Journal of Clinical Nutrition, 2010
- Randomized Controlled Pilot Study of Neuromuscular Electrical Stimulation of the Quadriceps in Patients with Non-Small Cell Lung CancerJournal of Pain and Symptom Management, 2009
- The anti-inflammatory effect of exerciseJournal of Applied Physiology, 2005
- Exercise normalises overexpression of TNF-α in knockout miceBiochemical and Biophysical Research Communications, 2004
- Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humansThe FASEB Journal, 2003
- ATS Statement: Guidelines for the Six-Minute Walk TestAmerican Journal of Respiratory and Critical Care Medicine, 2002
- A 30-s Chair-Stand Test as a Measure of Lower Body Strength in Community-Residing Older AdultsResearch Quarterly for Exercise and Sport, 1999